| |
| |
|
| Insider
Information: |
Peters Richard |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
89,126 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$53,739 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
89,126 |
|
|
| Total
Value |
$53,739 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 449.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merrimack Pharmaceuticals Inc |
MACK |
|
|
0 |
|
0 |
Premium* |
|
|
Kineta Ord Shs |
KA |
Director |
2022-12-16 |
88,097 |
2021-02-01 |
0 |
Premium* |
|
|
Aprea Therapeutics, Inc. |
APRE |
Director |
2023-08-23 |
1,029 |
2021-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2023-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
500 |
1,029 |
0 |
- |
|
| KA |
Kineta Ord Shs |
Director |
– • – |
2022-12-16 |
4 |
D |
$1.86 |
$3,592 |
D/D |
(1,931) |
88,097 |
0 |
- |
|
| KA |
Kineta Ord Shs |
President and CEO |
• • – |
2022-12-02 |
4 |
S |
$1.69 |
$18,418 |
D/D |
(10,890) |
90,028 |
0 |
% |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2022-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,995 |
10,605 |
0 |
- |
|
| KA |
Kineta Ord Shs |
President and CEO |
• • – |
2022-07-05 |
4 |
S |
$1.85 |
$8,476 |
D/D |
(4,584) |
100,918 |
0 |
% |
|
| KA |
Kineta Ord Shs |
President and CEO |
• • – |
2022-06-03 |
4 |
S |
$1.19 |
$12,192 |
D/D |
(10,206) |
105,502 |
0 |
% |
|
| KA |
Kineta Ord Shs |
President and CEO |
• • – |
2022-03-28 |
4 |
AS |
$1.85 |
$19,775 |
D/D |
(10,715) |
115,708 |
0 |
% |
|
| KA |
Kineta Ord Shs |
President and CEO |
• • – |
2021-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
126,423 |
0 |
- |
|
| KA |
Kineta Ord Shs |
President and CEO |
• • – |
2021-07-06 |
4 |
D |
$10.79 |
$852 |
D/D |
(79) |
56,423 |
0 |
- |
|
| KA |
Kineta Ord Shs |
President and CEO |
• • – |
2021-07-02 |
4 |
D |
$11.11 |
$49,340 |
D/D |
(4,441) |
56,502 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,610 |
4,610 |
0 |
- |
|
| KA |
Kineta Ord Shs |
President & CEO |
• • – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
60,943 |
60,943 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
